Andrew S. Roberts, Michael J. Campa, Elizabeth B. Gottlin, Chen Jiang, Kouros Owzar, Hedy L. Kindler, Alan P. Venook, Richard M. Goldberg, Eileen M. O'Reilly and Edward F. Patz Jr Identification of potential prognostic biomarkers in patients with untreated, advanced pancreatic cancer from a phase 3 trial (Cancer and Leukemia Group B 80303) Cancer 118
Version of Record online: 28 JUN 2011 | DOI: 10.1002/cncr.26270
Identification of prognostic biomarkers in patients with advanced stage pancreatic carcinoma may help stratify patients so that therapy can be individualized. The authors found that alpha 1-antichymotrypsin appears to be a prognostic marker in these patients. Further additional validation studies are suggested.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field